NEW YORK (GenomeWeb News) - Cepheid’s share price rose 5.4 percent, or $1.38, to $27.10 in mid-afternoon trading following the company’s announcement this morning that it is now shipping new versions of its GeneXpert system.
The company said the new system offers increased color capability, detection of up to 60 targets in one cartridge, and software for integrating laboratory information systems.